Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells
Francesca Virginia Bruschi, Thierry Claudel, Matteo Tardelli, et al.
Hepatology (2017) Vol. 65, Iss. 6, pp. 1875-1890
Open Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3331
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1272
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi, Scott L. Friedman, Yujin Hoshida
Advanced Drug Delivery Reviews (2017) Vol. 121, pp. 27-42
Open Access | Times Cited: 1198
Triggering and resolution of inflammation in NASH
Susanne Schuster, Daniel Cabrera, Marco Arrese, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 6, pp. 349-364
Closed Access | Times Cited: 746
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Juan Pablo Arab, Marco Arrese, Michael Trauner
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 13, Iss. 1, pp. 321-350
Open Access | Times Cited: 482
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yoon Mee Yang, Sohee Kim, Ekihiro Seki
Seminars in Liver Disease (2019) Vol. 39, Iss. 01, pp. 026-042
Open Access | Times Cited: 344
Update on NAFLD genetics: From new variants to the clinic
Eric Trépo, Luca Valenti
Journal of Hepatology (2020) Vol. 72, Iss. 6, pp. 1196-1209
Open Access | Times Cited: 318
Mechanisms of liver fibrosis and its role in liver cancer
Debanjan Dhar, Jacopo Baglieri, Tatiana Kisseleva, et al.
Experimental Biology and Medicine (2020) Vol. 245, Iss. 2, pp. 96-108
Open Access | Times Cited: 305
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future
Scott L. Friedman, Massimo Pinzani
Hepatology (2021) Vol. 75, Iss. 2, pp. 473-488
Open Access | Times Cited: 290
Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
Giovanni Musso, Maurizio Cassader, Elena Paschetta, et al.
Gastroenterology (2018) Vol. 155, Iss. 2, pp. 282-302.e8
Open Access | Times Cited: 271
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
Mohammed Eslam, Jacob George
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 1, pp. 40-52
Closed Access | Times Cited: 270
17‐Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease
Yanling Ma, Olga V. Belyaeva, Philip M. Brown, et al.
Hepatology (2018) Vol. 69, Iss. 4, pp. 1504-1519
Open Access | Times Cited: 252
A new perspective on NAFLD: Focusing on lipid droplets
Eleonora Scorletti, Rotonya M. Carr
Journal of Hepatology (2021) Vol. 76, Iss. 4, pp. 934-945
Open Access | Times Cited: 233
Sphingolipids in metabolic disease: The good, the bad, and the unknown
Christopher D. Green, Michael Maceyka, L. Ashley Cowart, et al.
Cell Metabolism (2021) Vol. 33, Iss. 7, pp. 1293-1306
Open Access | Times Cited: 190
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
Ali Saeed, Robin P. F. Dullaart, T.C.M.A. Schreuder, et al.
Nutrients (2017) Vol. 10, Iss. 1, pp. 29-29
Open Access | Times Cited: 187
Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
Olga A. Khomich, Alexander V. Ivanov, Birke Bartosch
Cells (2019) Vol. 9, Iss. 1, pp. 24-24
Open Access | Times Cited: 182
Cellular Mechanisms of Liver Fibrosis
Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 178
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello, Antonino Di Pino, Roberto Scicali, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1948-1948
Open Access | Times Cited: 171
Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
Alessandra Caligiuri, Alessandra Gentilini, Mirella Pastore, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2759-2759
Open Access | Times Cited: 167
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Frank Tacke, Tobias Puengel, Rohit Loomba, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 552-566
Closed Access | Times Cited: 165
Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD
Douglas G. Mashek
Molecular Metabolism (2020) Vol. 50, pp. 101115-101115
Open Access | Times Cited: 164
Association of metabolic dysfunction-associated fatty liver disease with kidney disease
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 4, pp. 259-268
Open Access | Times Cited: 151
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
Björn Carlsson, Daniel Lindén, Gabriella Brolén, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 51, Iss. 12, pp. 1305-1320
Open Access | Times Cited: 141
Novel therapeutic targets for cholestatic and fatty liver disease
Michael Trauner, Claudia Fuchs
Gut (2021) Vol. 71, Iss. 1, pp. 194-209
Open Access | Times Cited: 133
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top